HEMODYNAMIC ALTERATIONS IN CARDIOVASCULAR PATHOLOGIES: AN INTEGRATED BIO-PHYSICAL AND CLINICAL ANALYSIS
Main Article Content
Abstract
Hemodynamics, the study of blood flow and the forces governing circulation, represents a core component of cardiovascular physiology. Pathological disturbances in hemodynamic parameters—such as cardiac output, vascular resistance, vessel compliance, and blood viscosity—play a critical role in the initiation and progression of numerous cardiovascular and systemic disorders. Understanding these alterations is essential for predicting clinical outcomes, optimizing therapeutic strategies, and preventing organ dysfunction.
This study integrates bio-physical modeling with statistical analyses of clinical data to evaluate hemodynamic changes in heart failure, arterial hypertension, septic and hypovolemic shock, as well as microcirculatory dysfunction. Global data indicate that heart failure affects more than 64 million people worldwide, with 15–20% presenting with severe hemodynamic instability at diagnosis. Likewise, arterial hypertension—affecting over 1.3 billion adults—significantly alters vascular compliance and peripheral resistance, resulting in measurable disturbances in blood flow dynamics.
Key bio-physical principles, including Poiseuille’s law, Laplace’s law, and Bernoulli’s principle, were employed to quantify relationships between altered hemodynamic forces and pathological outcomes. Statistical analysis revealed significant correlations between increased peripheral resistance and impaired tissue perfusion, as well as between elevated blood viscosity and microvascular complications. The findings emphasize that deviations from normal hemodynamic patterns exacerbate tissue hypoxia, accelerate organ dysfunction, and worsen disease progression. Integrating quantitative bio-physical assessment into clinical monitoring supports earlier detection of pathological deviations and contributes to reducing morbidity and mortality.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Braunwald, E. Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier, 2021.
2.Guyton, A.C., Hall, J.E. Textbook of Medical Physiology. 14th ed. Philadelphia: Elsevier, 2020.
3.Nichols, W., O’Rourke, M. McDonald's Blood Flow in Arteries. 6th ed. Hodder Arnold, 2011.
4.Vincent, J.-L., & De Backer, D. Circulatory shock. New England Journal of Medicine, 2013; 369(18): 1726–1734.
5.World Health Organization (WHO). Cardiovascular Diseases: Global Statistics. 2024.
6.Popel, A., Johnson, P. Microcirculation and oxygen transport. Annual Review of Biomedical Engineering, 2005; 7: 221–246.
7.Levy, M.N., Pappano, A.J. Cardiovascular Physiology. 11th ed. Elsevier, 2018.
8.Rivers, E. et al. Early goal-directed therapy in severe sepsis. New England Journal of Medicine, 2001; 345(19): 1368–1377.